Nicole Buschmann

Person

Basel, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
- Patent number 10,786,492
- Issue date Sep 29, 2020
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
- Patent number 10,507,201
- Issue date Dec 17, 2019
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
- Patent number 10,189,813
- Issue date Jan 29, 2019
- Novartis AG
- Nicole Buschmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical combinations
- Patent number 10,130,629
- Issue date Nov 20, 2018
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
- Patent number 9,896,449
- Issue date Feb 20, 2018
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-fo...
- Patent number 9,802,917
- Issue date Oct 31, 2017
- Novartis AG
- Nicole Buschmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
- Patent number 9,533,988
- Issue date Jan 3, 2017
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
- Patent number 9,266,883
- Issue date Feb 23, 2016
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted isoquinolinones and quinazolinones
- Patent number 9,051,279
- Issue date Jun 9, 2015
- Novartis AG
- Joerg Berghausen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxy substituted isoquinolinone derivatives
- Patent number 8,859,535
- Issue date Oct 14, 2014
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted isoquinolinones and quinazolinones
- Patent number 8,440,693
- Issue date May 14, 2013
- Novartis AG
- Joerg Berghausen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-imidazolyl-indoles for the treatment of proliferative diseases
- Patent number 8,053,457
- Issue date Nov 8, 2011
- Novartis AG
- Andreas Boettcher
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
GLUE DEGRADERS AND METHODS OF USE THEREOF
- Publication number 20220363671
- Publication date Nov 17, 2022
- Novartis AG
- Jake AXFORD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS
- Publication number 20190231760
- Publication date Aug 1, 2019
- Novartis AG
- Nicole BUSCHMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Formylated N-heterocyclic derivatives as FGFR4 inhibitors.
- Publication number 20190105309
- Publication date Apr 11, 2019
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS
- Publication number 20190076412
- Publication date Mar 14, 2019
- Novartis AG
- Nicole BUSCHMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS
- Publication number 20180185341
- Publication date Jul 5, 2018
- Novartis AG
- Nicole BUSCHMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
- Publication number 20180065951
- Publication date Mar 8, 2018
- Nicole Buschmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMBINATIONS
- Publication number 20180064709
- Publication date Mar 8, 2018
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
- Publication number 20170066766
- Publication date Mar 9, 2017
- Novartis AG
- Nicole Buschmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-fo...
- Publication number 20160304489
- Publication date Oct 20, 2016
- Novartis AG
- Nicole BUSCHMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
- Publication number 20160102092
- Publication date Apr 14, 2016
- Novartis AG
- Nicole Buschmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
- Publication number 20150119385
- Publication date Apr 30, 2015
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HDYROXY SUBSTITUTED ISOQUINOLINONE DERIVATIVES
- Publication number 20140135306
- Publication date May 15, 2014
- Novartis AG
- Nicole Buschmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED ISOQUINOLINONES AND QUINAZOLINONES
- Publication number 20130281473
- Publication date Oct 24, 2013
- Joerg BERGHAUSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Isoquinolinones and Quinazolinones
- Publication number 20110230457
- Publication date Sep 22, 2011
- Novartis AG
- Joerg BERGHAUSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-Imidazolyl-Indoles for the Treatment of Proliferative Diseases
- Publication number 20100125064
- Publication date May 20, 2010
- Novartis AG
- Andreas Boettcher
- C07 - ORGANIC CHEMISTRY

Nicole Buschmann

Person

Patents Grantslast 30 patents

Formylated N-heterocyclic derivatives as FGFR4 inhibitors

Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Formylated N-heterocyclic derivatives as FGFR4 inhibitors

Pharmaceutical combinations

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-fo...

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Substituted isoquinolinones and quinazolinones

Hydroxy substituted isoquinolinone derivatives

Substituted isoquinolinones and quinazolinones

3-imidazolyl-indoles for the treatment of proliferative diseases

Patents Applicationslast 30 patents

GLUE DEGRADERS AND METHODS OF USE THEREOF

USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS

Formylated N-heterocyclic derivatives as FGFR4 inhibitors.

USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS

USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS

Formylated N-heterocyclic derivatives as FGFR4 inhibitors

PHARMACEUTICAL COMBINATIONS

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-fo...

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

HDYROXY SUBSTITUTED ISOQUINOLINONE DERIVATIVES

SUBSTITUTED ISOQUINOLINONES AND QUINAZOLINONES

Substituted Isoquinolinones and Quinazolinones

3-Imidazolyl-Indoles for the Treatment of Proliferative Diseases